The Philippines intends to sue Sanofi after authorities suspended the pharmaceutical giants anti-dengue vaccine in response to the company warning the drug could lead to severe infections in some cases, the health secretary said Thursday.
Regulators froze the Philippines' world-first public dengue immunisation programme last week and suspended all sales of the vaccine on Monday after Sanofi said Dengvaxia could worsen symptoms for vaccinated people who contracted the disease for the first time.